Phase III

Phase III of a clinical trial involves testing a new treatment or drug on a large group of people to evaluate its effectiveness and safety. This phase compares the new treatment to standard therapies or a placebo to determine how well it works and identify any side effects. The goal is to gather enough data to ensure the treatment is both beneficial and safe for widespread use. Successful Phase III results are usually required before seeking approval from health authorities to make the treatment available to the general public.